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ant/bum,’ .mndrorne I/4PS can cAns/cm mu/ti/c,
muitanecus cr/can-system thromboernbcm; disease.
which/s urlhrrc dtoasthecatastrophicanl/chosoholipid
antibody srrldrome (CA PS). Roughly one-Ira/f otthese
patients have systeaf lupus erythematc’sus ISLE).
Factors known to ørecieitate CAPS includb infection,
surgery. trauma, neopiasia. anticoaguILt/on vhthdrawal.
ofstetric cc aimcations, and SLE flares. Optimal
treatment /nc/udes ant/coagulation and high-dose
cortosterojos, although 1VIG ano plasma escrlange
no e Th0 coera r 05
is mu knA. .bL.it mpt clinibal recugn/t/cn c this
(L.atastivph ic antiphosphohpid ritlbodS r rirome
C”APS a rare clinical subset of’ the nuphospho—
hpid antihod Sr ndrome APS occurring ii le than
I ta ot patients. This nndronw presents acutcir ‘ th
multi—orsan thr mirosis and Failure. with an associ
ated 50”’ nuartalitr rate. We descnhe an Ilustratae
case and discuss risk factors. chnical features and
treatment options (or this uncommon ret des astatinu
syndrome.
Case Report
A 37 year-ok) Caucasian female presented to our facil
ity with a diagnosis of systemic lupus erythematosus
(SLFI). Her disease was manifested pres tously by
arthritis, pleurisy. Raynaud’s phenomenon. hypo
complementeinia,positiveautoantihodies (antinuclear.
double-stranded l)NA. and rihonuclcoprotein) arid a
positi \ e lupus anticoagulant test without prior throw
butte es ent Hcrdiseasc was stable on hr dross chioro
inc and loss -d sc prednisone. Ses era! nionth5 later.
she prcsented to icr priman care clinic a ith sr mptoms
ot dr sura and a urinals/cs that resealed pr aria
hacteruria. She sias treatedwith sul[anietho\a/ole’tri-’
methoprn’. hut presented at our institution three dars
tatcrcomplainins of nausea. vomiung. loss -grade (Cuer
and di flu se abdom na! d icom tArt.
Phr steal examination revealed mild ta/cr ei0ia.
tim ci’ to I (.11 (1 F. and dOuse abdominal tenderness
without ormnomceai\ or pertoneal signs. She a
neurologIcal Ir’ i n tnt. and her skin. exam did not revea
cyanosis. lisedo reti.cularis, pete.ehiae or purpura.
Laboratory studies revealed a normal white blood cc
count of 5L(9 per rum3 (3.5-I. 1,0. low hemoglobin
5.7g/dL(i 1,7-15.7) andheniatoc.ri.t 1.5% (3571-4)7 t, 1,
elevated mean corpuscular volume 1.12. IL (80—100).
and low platelet count of ‘113,0(X) (150,000-440,000).
The peripheral smear showed. polychromas.i.a, mild
thrombocytopenia without c.iumpmg, and no schis
tocytes. Her scram creatinine, elesotrolytes, and
hepatic panel a crc normal hut coagulatton stud es
revealedn’itldprolongationofprothromhin and partial
thromboplastin times at I seconds t l0.7- 13. I aid
46 seconds 24-3S I. ‘espeetlscty. [-urinogen “. as
ton’rial hut haptovh hi was < 20 mc”;’di 3t7—2i it);.
lactate dehydrogenase svar elevated at 885. 0 0 194.
250’t. Coomb’s diect antibody test was positS e an5
the retcnlocr te cones a as elevated at 16.7/c (.5—
1.5 i. 0rinalvs is a unremarkable except (or train’
protein.
She svas l’elt to has c prolound hensolr tic anemia.
which a as treated si ith high-dose intravenous Sort
eosteroids I .000 trig of methyIprednisolone tss ice
per day) and intrascrtous gammaglohulin (1VIG if!
gram perkilograni t.S’he was transfused with onlr one
unit of packed red blood cells because she had cross
reactin antibodies to all other available. units in our
blood hank, Her h.ematocri.t stabilized at 26% and her
piateie.tcountimproved to 246,000. The PIT trnained
prolonged and did not correct with 1:1 mixing studes.
iuprts anticoaculant (irs diluted. Russell viper sen. an
time) was positive and Ii hrin D-dimer wase levat5 ii at
22cc nil (l ( 80 kr/sd toni m tO ii
chest and abdomen resealed muhirle bilateral lung
akeotar opacities. ‘ma] I bilateral pleural cPus ‘its.
pe’ieholecr stic )1ud and hspodensitics in the spIcy’.
and kidne s consIstent wit! int’aretons.
Her condition rap/cr deteriorated. mani’lested h
increased respirator) distress and hvtx’xeniia. a heir
uitrnatcir’ rc’sluired rnes’hanieai ventilation, along with
mental status changes. Pulmonary artery catheteriza
tion shoss edelesated pnlnionarr arterial pressur’s a ith
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a normal pulmonary capillary wedge pressure. Given
her elevated D-dimer. hypercoagulability (positive
lupus anticoatulant) and elevated pulmonary artery
pressures. a diagnosis of pulmonary embolus was
considered and thrombolytic therapy entertained.
[1os ever, fibrinolytic therapy was felt to he relativel
contraindicated given heracute mental status changes.
profound anemia and mild thrombocvtopenia ss ithout
as ailable blood product support in case of a hemor
rhage A head CT was quickl\ done to assess for
ntracranial hemorrhaee and a CT pulmonar angi
gram performed to evaluate for pulmonar enTholus.
hut hoth studies were unremarkable.
Her pulmonary artery catheterization, chest radio—
graph and clinical findings were felt to be consistent
with adult respirator distress syndrome ARDS
hut she eventually expired despite aggressivc man
agement An autopsy res ealed splcnic and renal
infarctions with thrombosis. pericardial and pleural
ef’f’usions. and pulmonary edema. Several small and
medium-sized vessels in both lungs had thrombi and
a large thrombus was observed in her right ventricle.
Herclinical tindin sofhemolvtie anemia, multi—organ
thrombosis, and ARDS in association with positive
lupus anticoagulant svere consistent with a post—mor
tem diagnosis of’ CAPS.
Discussion
CAPS was only recently described as a rare mani
festation of APS associated with multiple ascular
occlusive events and multi—organ failure. \vith the first
reported case in 1992 byAsherson. He later provided
acomprehensive and detailed review of the clinical and
laboratory features of CAPS in I 995,2 but expanded
this review three years later to include a total of So
patients collected from multiple medical centers.
There is no general concensus regarding the diagnos
tic criteria for the diagnosis of CAPS, hut most accept
the presence of thrombotic vascular occlusion in at
least three different organ systems. presenting acutely
over days to weeks, in patients with antiphospholipicl
antibodies,4A recent international workshop on APS
discussed diagnostic criteria for the classification
of CAPS. They proposed four criteria, to include
involvement of at least three organ systems and/or
tissues, onset in less than one week, histopatholoric
confirmation of small vessel involvement in at least
one organ or tissue, and laboratory confirmation of
antiphospholipid antibodies, A definite diagnosis of
CAPS was considered when all four criteria were
met, while a probable diagnosis was considered vvhen
only two organs and/or tissues were involved (Table
Thrombosis appears to occurequally in arteries and
seins in CAPS. hut kmales are affected three times
more often than men. withthe mean age ofonset being
37 sears. In a i’es iess of 1.000 patients ss ith APS over
a sesen-y earperiod. the incidence otCAPS v as noted
to he 0.S. Interestinelv. CAPS was the presenting
manifestation in ( of the S patients who ultimately
des eloped this. Roughl\ one—halt’ of those affected
ss tb CAPS also had s\stemic lupus ervthematosus
S[.F/ ss hile the other half appeared to have primary
APS (Table 2>.
The pathocenesis of CAPS is unknown, but pre
cipitatino factors have been identified such as pre
ceding infections 35(/ , surgerY or trauma t I 3 f.
neoplasia (8%). anicoaculation withdrawal (5(/ )
obstetric complications tö%), SLE flares (5(/
.
and
oral contraceptive use 35f ). No precipitating factor
is identified in approximately one—third of patients.
Kitchens discussed a “thrombotic storm” theorv.
ss here thrombosis leads to additional thrombosis
and fibrinolvtic shutdown. Others have pmposed a
“double/triple” hit theory, where a patient ss ith Sl.E
or malignancy has an infection, trauma, or surgery
and anticoagulation is withheld, leading to a cascade
of thrombotic complications.’1
i’here are several common clinical and laboratory
mani tèstations ofCAPS (Table 2). The most common
clinical findings include cardiopulmonary involve
ment (25%) (pulmonary embolus and ARDS), CNS
in volvement (22%), abdominal pain (22%), and fever
10%). These were all clinical manifi/stations noted
in our patient. Less common presenting manifesta
tions include renal impairment (14%) and cutaneous
involvement (9%). Any organ system may ultimately
he affected, hut organs most commonly affected were
kidnv.s78) lungs(66ff) CNSf56%) hvartt50)
skin (50%). and hematologic (with diffuse intravascu
ar coagulation) (25ff;). Common laboratory findings
include thrombocytopenia (60%). hemolytic anemia
(3Y/) features of DIC (19%), and schistocytes on
peripheral smear (9%). As mentioned previously, all
Table 1.— Recently adapted diagnostic criteria for the classification of CAPS.’
Diagnostic criteria used n the cIasfication ot CAPS
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pal .iits s nbC \PS ha e anliphospholipid antibodies
‘a ith ,(i ha inehieh—titeri.ardi lipm antibodies and
(‘Se ha inc lupus inticoaculam.
Mans t in nts has e h un u d in C \PS. ‘a ith
\ ar\ in )l 511 eSs tT 1 ) I herapx s th
nti s I t n ( m ( ( ) isa
nii ii nI i As r i s s hut h r
re n asi i ( I ) in F\ IC
(1 D t t .r ssi tr n m r i
rite of C P pr aches C) i ith ii plc
sei.ondais AR[)S and ni miii i r ri tnhire.
thet apeutli. nter\ entu ‘n has e cii. ai I\ been sho ii
to nnpros e -urs is al in dati. lthon.h ihesu pal tents
sh in Id he manaced it an ink nsis C cars sen mu and
sir i inc onsider ation should he ems en to the use oF
anti. oaculation and Ii me [i—doses ol steroids Ris
sihie piesmpmLttmie factors should he treated and or
eliminated \ itihmot cs for ted mntec tion
should b nd dehridi.m nt )C ni.emtmc ti, u
slioul b p rm Se o un t ent op i ns
iimii i’v IG mdi pla h n s m h or s th
)ut r sh troien p1 ma. C phos hi ide h uld
he consid r d in p itmenls not spi. n in to th r p
espes mall in th ettmne ol an SLF I Our patmunt
ici. em\ ed hi h dose eorticostcroids and I \ I(. hut
did not ieeeis e antmeoagulaiion plasmapheresis or
e\ elophosphamide.
Our patient presented is ith ses crc hemol Ire ane
mia and rapidlx des eloped multi orcan tailure is ith
ARDS. Her i.ase appear to he representatmi c of the
t\ pus al cli nii. l manifestations and outs nine seen i\ ith
C APS. Fortunatels.. this si ndrom )nl\ osi. uus in Ic s
than I ( dl p itients isith PS Ut U uall presents
asut Is Tb dia nosis is usu 1l mid h\ clmni il
ab rator . a mc c i u d hi ft p itholo i Imndin
hut ant mc rt n dma no i n lu is lnsr d
ph\ sm m n r ni., s ol thu nd hr pefulls vii
result n i pid dmacnosis t merit thou
it remains t s h deft r mined ii thu ill ultumati. l lead
mmprosed Jinisal oukonles.
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Table 2.— Common clinical and laboratory findings in CAPS,
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Table 3.—Therapeutic modalities used in the treatment of CAPS.
Ar’tccagaaton
Ccrhcosrerons
Anibmics for suspected Intections
Debridement ot any necrotIc tissue
Consider IVIG and/or plasma exchange as second line therapy
Consider cyclophosphamide It not responding to the above therapies
Until there’s a cure
there’s the
American Diabetes
Association.
364
